We have identified you may not be viewing TRAVAX optimally because the browser you are using is unsupported - click here.
We have identified you may not be viewing TRAVAX optimally because the browser you are using is unsupported - click here.
The European Centre for Disease Prevention and Control (ECDC) reported that as of 19 June 2021, 68,330 cases of chikungunya disease have been reported in Brazil in 2021, including 27,353 confirmed cases and 5 deaths. This is an increase of 20,286 cases and 2 deaths since 22 May 2021.
Compared with the same period last year (2020) there has been a significant rise in cases. As at 28 June 2020, 48,316 probable cases (no confirmed data) and 11 deaths were recorded.
Advice for Travellers
Chikungunya is a viral infection spread by mosquito bites that can cause acute fever and severe joint pain.
All travellers to endemic regions are potentially at risk of chikungunya and should be aware of this infection. Prevention relies on avoiding mosquito bites at all times.
No vaccine is available against Chikungunya.
Travellers who develop a fever during travel, or once they return home are advised to seek medical advice as soon as possible and mention their travel history.
For further information see TRAVAX Chikungunya page.
